Claritas Pharmaceuticals Inc CLAZF

Analysis on todays NR

[PTBailey]

Analysis, insights, clarification and explanation on todays NR re. Letter of Intent (the “LOI”) with Biozeus Biopharmaceutical on Claritas Investors.

https://claritasinvestors.com/index.php?%2Ftopic%2F1113-claritas-announces-option-to-acquire-rights-to-novel-drug-for-treatment-of-covid-19-related-ards%2F&tab=comments&fbclid=IwAR1NrfMSA7c7RMr3-fwdYBJZVrIMoRQrtAx7GY4JDREfYx_Vf33SMgF457k#comment-3785

[Dude51]

Just another BS story from DREW which I have been blocked from viewing, What's the matter DREW can't handle critizem or truth or both?

[PTBailey]

Here it is so you can see it. SAN FRANCISCO and TORONTO, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Claritas Pharmaceuticals, Inc. (TSX VENTURE: CLAS and OTC: CLAS.V) (the "Company" or "Claritas") today announced that it has entered into a binding Letter of Intent (the “LOI”) with Biozeus Biopharmaceuticals S. A., a Brazilian corporation (“Biozeus”), under which Biozeus will grant

[Yukon78]

Get lost. Have't you got better things to do, liike mowing your Mom's lawn.

[Dude51]

Sure thing Yukon err. Since its inception in July 2014, Claritas has accumulated a deficit of approximately $59.2 million as at June 30, 2021. The Company did not generate any revenue from product sales during the three months period ended June 30, 2021. Claritas expects its operating losses to continue in the next fiscal year as it invests in its product development programs. Go here https

[PTBailey]

Since claritas is a R&D company using money rasied by investors and private placements they are are working towards producing something that other pharma companies will aquire licenses and put to market.  A $59.2 million defecit does not mean they have debt, actually I beleive they are debt free. And I would say you are correct they will invest more money in completing phase 1 and 2. So